MedTrace Logo

Acceptability Study on Nutricomp® Drink Plus Fibre in Adults

NCT03013803 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2017-08-11

No results posted yet for this study

Summary

Required for Advisory Committee for Borderline Substances (ACBS) approval. Aim of this study is to access the palatability, compliance and GI-tolerance of Nutricomp® Drink Plus Fibre to show that it is acceptable for patients in the United Kingdom.

Conditions

  • Adult Patients in Need of High-energy Oral Nutritional Supplementation

Interventions

DIETARY_SUPPLEMENT

Nutricomp Drink Plus Fibre

Sponsors & Collaborators

  • B. Braun Melsungen AG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03013803 on ClinicalTrials.gov